Market closed

Kronos Bio/$KRON

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Kronos Bio

Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription. The company operates in one business segment, the development of biopharmaceutical products.

Ticker

$KRON
Trading on

Industry

Biotechnology

Employees

63

Kronos Bio Metrics

BasicAdvanced
$56M
Market cap
-
P/E ratio
-$1.44
EPS
1.86
Beta
-
Dividend rate
$56M
1.86
$1.60
$0.69
354K
8.316
8.117
20.282
23.215
-46.83%
-25.13%
-59.08%
5.603
0.5
0.5
-0.712
146.48%
-30.87%
-14.63%

What the Analysts think about Kronos Bio

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Kronos Bio stock.

Kronos Bio Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Kronos Bio Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $KRON

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Kronos Bio stock?

Kronos Bio (KRON) has a market cap of $56M as of December 21, 2024.

What is the P/E ratio for Kronos Bio stock?

The price to earnings (P/E) ratio for Kronos Bio (KRON) stock is 0 as of December 21, 2024.

Does Kronos Bio stock pay dividends?

No, Kronos Bio (KRON) stock does not pay dividends to its shareholders as of December 21, 2024.

When is the next Kronos Bio dividend payment date?

Kronos Bio (KRON) stock does not pay dividends to its shareholders.

What is the beta indicator for Kronos Bio?

Kronos Bio (KRON) has a beta rating of 1.86. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.